Giulia Lorenzini

460 total citations
11 papers, 305 citations indexed

About

Giulia Lorenzini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Giulia Lorenzini has authored 11 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Giulia Lorenzini's work include Advanced Breast Cancer Therapies (4 papers), Respiratory viral infections research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Giulia Lorenzini is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Respiratory viral infections research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Giulia Lorenzini collaborates with scholars based in Italy and Australia. Giulia Lorenzini's co-authors include Matteo Ghilli, Paola Ferrari, Andrea Nicolini, Cristian Scatena, Niccolò Marchionni, Domenico Barone, Enrico Mossello, Carolina Piccini, Anna Maria Mello and Giulio Masotti and has published in prestigious journals such as International Journal of Molecular Sciences, Pharmacological Research and Cancers.

In The Last Decade

Giulia Lorenzini

7 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Lorenzini Italy 7 128 109 105 76 60 11 305
Ghazaleh Zarrinrad Iran 10 88 0.7× 92 0.8× 20 0.2× 32 0.4× 21 0.3× 12 260
Fatemeh Vahidian Iran 10 164 1.3× 160 1.5× 47 0.4× 103 1.4× 5 0.1× 16 370
Jennifer Doig United Kingdom 10 37 0.3× 256 2.3× 50 0.5× 23 0.3× 66 1.1× 14 353
Chao Zeng China 10 111 0.9× 170 1.6× 72 0.7× 84 1.1× 10 0.2× 25 351
Patrick B. Thomas Australia 13 85 0.7× 188 1.7× 56 0.5× 81 1.1× 25 0.4× 29 378
Douglas Laux United States 11 112 0.9× 474 4.3× 72 0.7× 56 0.7× 133 2.2× 34 674
Raymond Clark United States 5 67 0.5× 249 2.3× 12 0.1× 55 0.7× 52 0.9× 6 376
Junnian Zheng China 10 116 0.9× 110 1.0× 27 0.3× 32 0.4× 53 0.9× 12 371
Paramita Ray India 10 48 0.4× 258 2.4× 31 0.3× 185 2.4× 16 0.3× 26 455

Countries citing papers authored by Giulia Lorenzini

Since Specialization
Citations

This map shows the geographic impact of Giulia Lorenzini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Lorenzini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Lorenzini more than expected).

Fields of papers citing papers by Giulia Lorenzini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Lorenzini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Lorenzini. The network helps show where Giulia Lorenzini may publish in the future.

Co-authorship network of co-authors of Giulia Lorenzini

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Lorenzini. A scholar is included among the top collaborators of Giulia Lorenzini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Lorenzini. Giulia Lorenzini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Micheletto, Claudio, Giulia Lorenzini, Sara De Grazia, et al.. (2025). Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based survey. Human Vaccines & Immunotherapeutics. 21(1). 2552557–2552557.
3.
4.
Crucitta, Stefania, et al.. (2023). CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients. Cancers. 15(4). 1306–1306. 11 indexed citations
5.
Re, Marzia Del, Stefania Crucitta, Claudia Omarini, et al.. (2022). Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib. The Breast. 66. 157–161. 16 indexed citations
6.
Ferrari, Paola, et al.. (2022). Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC. International Journal of Molecular Sciences. 23(3). 1665–1665. 120 indexed citations
7.
Re, Marzia Del, Claudia Omarini, Michela Palleschi, et al.. (2021). Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. ESMO Open. 6(5). 100231–100231. 37 indexed citations
8.
Re, Marzia Del, Stefania Crucitta, Giulia Lorenzini, et al.. (2020). PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients. Pharmacological Research. 163. 105241–105241. 29 indexed citations
9.
Mossello, Enrico, Anna Maria Mello, Giulia Lorenzini, et al.. (2011). Animal-assisted activity and emotional status of patients with Alzheimer's disease in day care. International Psychogeriatrics. 23(6). 899–905. 70 indexed citations
10.
Milillo, Lucio, et al.. (2007). Prognostic value of differential expression of Laminin-5 γ2 in oral squamous cell carcinomas: Correlation with survival. Oncology Reports. 18(4). 793–800. 22 indexed citations
11.
Lorenzini, Giulia, et al.. (1975). [Regional chemotherapy of stomach cancers].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 51(9). 601–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ghazaleh Zarrinrad Breakdown of academic impact, for papers by Fatemeh Vahidian Breakdown of academic impact, for papers by Jennifer Doig Breakdown of academic impact, for papers by Chao Zeng Breakdown of academic impact, for papers by Patrick B. Thomas Breakdown of academic impact, for papers by Douglas Laux Breakdown of academic impact, for papers by Raymond Clark Breakdown of academic impact, for papers by Junnian Zheng Breakdown of academic impact, for papers by Paramita Ray
Rankless by CCL
2026